In the progressive forms of MS, the CD4+ and CD8+ T cells and the B cells seem to be part of the pathological mechanisms, although with characteristics that differ from those observed in RRMS and without a clear correlation between immune cell activation and clinical measures of disease duration and severity, especially in PPMS [121]. This evidence concerns the gene CD8A and myeloid sarcoma.